CLINE-B.ST
Cline Scientific AB (publ) [CLINE-B.ST] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CLINE-B.ST Stock Summary
In the News
CLINE-B.ST Financial details
Company Rating
-
Market Cap
5.81M
Income
-3.25M
Revenue
1.45M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
2
Optionable
No
Shortable
Yes
Earnings
-
P/E
-2.01
Forward P/E
-
PEG
-0.29
P/S
-
P/B
0.27
P/C
-
P/FCF
-1.4
Quick Ratio
7.06
Current Ratio
7.52
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.17
EPS next Y
-
EPS next Q
-
EPS this Y
1.01%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-14.59%
Revenue last 5Y
-100%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-13%
ROE
-14%
ROC
-0.13%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.1005-1.054228
52W High
-
52W Low
-
RSI
-
Rel Volume
1.45
Avg Volume
19.66K
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
0.491
-
-
Volatility
0%, 0%
Prev Close
-
Price
-
Change
-
Company Profile
- Volume Average 19.66K
- Market Capitalization 5.81M
- Employee 2
- CEO Mr. Anders Patrik Sundh
- Headquarters Mölndal,SE
- IPO Date 2015-03-30
-
Website
https://www.clinescientific.com 
Cline Scientific AB (publ) develops cancer diagnostics and regenerative medicine treatments in Sweden. It develops an allogenic stem cell therapy based on induced pluripotent stem (iPS) cells. The company also develops surface nanotechnology for cell-based products and processes to drive projects within life science into the clinical phase. It has collaboration with AstraZeneca to utilize gradient technology. Cline Scientific AB (publ) was founded in 2012 and is based in Mölndal, Sweden.
